miR-1908对人内脏前体脂肪细胞增殖、细胞凋亡和细胞周期的影响

doi:10.3877/cma.j.issn.2095-9605.2019.02.003

中华肥胖与代谢病电子杂志 ›› 2019, Vol. 05 ›› Issue (02) : 79 -84. doi: 10.3877/cma.j.issn.2095-9605.2019.02.003

所属专题：文献；

论著

miR-1908对人内脏前体脂肪细胞增殖、细胞凋亡和细胞周期的影响

郭冰冰¹, 付锦艳¹, 裴晶晶¹, 蒋新液¹^,^†(

)

^1. 214002　无锡，南京医科大学附属无锡妇幼保健院

收稿日期:2019-04-01 出版日期:2019-05-30
通信作者: 蒋新液
基金资助:
无锡市"科教强卫工程"医学青年人才项目(QNRC091)

Effects of miR-1908 on cell proliferation, cell cycle, apoptosis of human preadipocytes-visceral

Bingbing Guo¹, Jinyan Fu¹, Jingjing Pei¹, Xinye Jiang¹^,^†()

^1. Department of the Children Health, The Affiliated Wuxi Matemity and Child Health Care Hospital of Nanjing Medical University, Wuxi 214002, China

Received:2019-04-01 Published:2019-05-30
Corresponding author: Xinye Jiang
About author:
Corresponding author: Jiang Xinye, Email: fyjxy2110@163.com

全文 ( ) 下载PDF ( ) 导出引用

目的

研究miR-1908对人内脏前体脂肪细胞（HPA-v）增殖、细胞凋亡和细胞周期的影响。

方法

体外培养HPA-v脂肪细胞,并根据实验分为抑制剂组（转染经化学修饰的miR-1908-5p抑制剂）、空载体组（转染空载体）、对照组（未进行任何处理），CCK8（Cell Counting Kit-8）法用于检测细胞的增殖情况，流式细胞仪检测细胞周期、Tunnel法检测细胞凋亡情况。

结果

CCK8结果显示miR-1908抑制剂组的吸光度（OD）值（0.61±0.07）明显低于对照组（1.01±0.05）（P<0.05），抑制miR-1908具有抑制HPA-v脂肪细胞增殖的作用；Tunel结果表示miR1908抑制剂组凋亡率（0.27±0.03）%明显大于对照组（0.13±0.05）%（P<0.05）；流式细胞测定的结果为G0/G1期细胞增加（与对照组相比，P<0.05），表明抑制miR-1908表达可能通过诱导HPA-v脂肪细胞G0/G1期阻滞抑制HPA-v脂肪细胞增殖。

结论

下调miR-1908表达能明显抑制人内脏前体脂肪细胞增殖，诱导细胞凋亡及改变细胞周期分布。

关键词: miR-1908, 脂肪细胞, 增殖, 凋亡, 细胞周期

Objective

To study the effect of miR-1908 on cell proliferation,cell cycle,apoptosis of human preadipocytes-visceral.

Methods

human preadipocytes-visceral were cultured and divided into three treatment groups—inhibitor group (transfected with chemically modified miR-1908-5p inhibitor), empty vector group (transfected empty carrier) and control group (without any treatment).CCK8 assay was used to detect the proliferation of HPA-v, Tunnel method was used to detect the apoptosis, Flow cytometry was used to detect cell cycle.

Results

CCK8 assay showed that the absorbance values of miR-1908 inhibitor group (0.61±0.07) was significantly lower than that of the control group (1.01±0.05) (P<0.05). Tunel results showed that the apoptotic rate of miR-1908 inhibitor group (0.27±0.03)% was significantly higher than that of control group (0.13±0.05)% (P<0.05). The results of flow cytometry showed that miR-1908 inhibitor might induce the G0/G1 phase cell cycle arrest.

Conclusions

Inhibition of miR-1908 expression could significantly inhibit HPA-v cell proliferation, induced apoptosis and change the cell cycle distribution.

Key words: MiR-1908, Adipocytes, Proliferation, Apoptosis, Cell cycle

图1 细胞培养图

图2 转染miR-1908抑制剂后，CCK8法检测对HPA-v脂肪细胞增殖的影响

图3 转染miR-1908抑制剂后各组脂肪细胞凋亡观察图

图4 转染miR-1908抑制剂后HPA-v脂肪细胞凋亡结果分析柱状图

图5 转染miR-1908抑制剂后，流式细胞术检测各组HPA-v脂肪细胞周期情况

图6 流式细胞术检测miR-1908表达变化对各组脂肪细胞周期的影响

[1]	Upadhyay J, Farr O, Perakakis N, et al. Obesity as a Disease[J]. Med Clin North Am, 2018, 102(1): 13-33.
[2]	Schulze MB. Metabolic health in normal-weight and obese individuals[J]. Diabetologia, 2019, 62(4): 558-566.
[3]	Caterina C, Carlo C, Giuseppe Z. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions[J]. International Journal of Molecular Sciences, 2016, 17(10): 1712.
[4]	Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
[5]	Cruz KJ, de Oliveira AR, Morais JB, et al. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity[J]. Nutrition, 2017, 35: 28.
[6]	Zhong H, Ma M, Liang T, et al. Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response[J]. Journal of Immunology Research, 2018, 2018(4): 1-8.
[7]	Goody D, Pfeifer A. MicroRNAs in brown and beige fat[J].Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864(1): 29-36.
[8]	Bar M, Wyman SK, Fritz BR, et al. MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries[J]. Stem Cells, 2008, 26(10): 2496-2505.
[9]	Yang L, Shi CM, Chen L, et al. The biological effects of hsa-miR-1908 in human adipocytes[J]. Molecular Biology Reports, 2015, 42(5): 927-935.
[10]	占猛斯. miR-425对3T3-L1细胞分化的抑制作用研究[D]. 武汉: 华中农业大学, 2006.
[11]	Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child[J]. Bmj, 2017, 356: j1.
[12]	Hall ME, Wang Z, Carmo JD, et al. Obesity and Metabolic Syndrome Hypertension[J]. Disorders of Blood Pressure Regulation.2018, 705-722.
[13]	Mcbride DL. Childhood Obesity: Influential Factors and Interventions[J]. Journal of Pediatric Nursing, 2018, 42: 122-123.
[14]	Lakerveld J, Mackenbach J. The Upstream Determinants of Adult Obesity[J]. Obes Facts. 2017, 10(3): 216-222.
[15]	Kilic ID, Dodurga Y, Uludag B, et al. MicroRNA -143 and -223 in obesity.[J]. Gene, 2015, 560(2):140-142.
[16]	Shi C, Huang F, Gu X, et al. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity[J]. Oncotarget, 2016, 7(26): 40830-40845.
[17]	Noman A, Fahad S, Aqeel M, et al. miRNAs: Major modulators for crop growth and development under abiotic stresses[J]. Biotechnology Letters, 2017, 39(5): 685-700.
[18]	Ying W, Riopel M, Bandyopadhyay G, et al. Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity[J]. Cell, 2017, 171(2): 372.
[19]	Ghanbari M, Sedaghat S, Looper HWJ, et al. The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose[J]. Obesity, 2015, 23(2): 495.
[20]	Jiang X, Yang L, Pang L, et al. Expression of obesityâ related miRâ 1908 in human adipocytes is regulated by adipokines, free fatty acids and hormones[J]. Molecular Medicine Reports, 2014, 10(2): 1164-1169.
[21]	杨蕾. miR-1908在人脂肪细胞中的功能研究[D].. 南京: 南京医科大学, 2016.
[22]	秦一雨，全志伟，李松岗. microRNA调控细胞周期的研究现状[J]. 中华医学杂志, 2010, 90(40): 2873-2875.

[1]	李康, 冀亮, 赵维, 林乐岷. 自噬在乳腺癌生物学进展中的双重作用[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 195-202.
[2]	孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[3]	张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[4]	刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[5]	江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[6]	刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[7]	郑嘉裕, 吴建杰, 李小娟, 曾恒达, 李国邦, 黄炯煅, 温星桥. hsa_circ_0090923在前列腺癌中的表达及其对前列腺癌细胞增殖和迁移的调控[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 276-283.
[8]	莫钊鸿, 翟航, 苏日顺, 孟泓宇, 罗豪, 陈文豪, 许瑞云. U2AF2表达对肝细胞癌增殖和迁移的影响及其与预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 336-341.
[9]	樱峰, 王静, 刘雪清, 李潇. 水通道蛋白1对人角膜内皮细胞增殖、迁移及凋亡影响的实验研究[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 146-151.
[10]	于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[11]	邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[12]	张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[13]	方辉, 李菲, 张帆, 魏强, 陈强谱. 外源性瘦素对梗阻性黄疸大鼠肠黏膜增殖的影响[J]. 中华临床医师杂志(电子版), 2023, 17(05): 575-580.
[14]	郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15]	邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effects of miR-1908 on cell proliferation, cell cycle, apoptosis of human preadipocytes-visceral

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effects of miR-1908 on cell proliferation, cell cycle, apoptosis of human preadipocytes-visceral